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Foot-and-Mouth Disease Virus (FMDV) is a positive stranded picornavirus which 
infects cloven-hoofed animals, such as cattle, pigs and sheep, and leads to severe 
losses in livestock production. In the case of an FMD outbreak, emergency vaccination 
could be used but it would require at least 7 days to trigger an effective immune 
response. On the contrary, the use of antiviral drugs is expected to have prophylactic 
and/or therapeutic effects almost immediately. However, there are currently no 
approved FMDV inhibitors. Here we have applied a combination of screening, 
biochemical, virological, and molecular modeling tools to discover, validate, and 
characterize novel inhibitors of FMDV replication. Using a luciferase-based assay we 
have screened a chemical library of compounds and have identified two compounds, 5-
chloro-3-(thiophen-2-yl-sulfanylmethyl)-1-benzothiophene 1,1-dioxide (or C7F8) and 
N'1-thieno[2,3-d]pyrimidin-4-yl-4-chloro-1-benzenesulfonohydrazide (or C5D9) that 
inhibited the RNA-dependent RNA polymerase activity of FMDV replicase (3Dpol) with 
IC50 values of 2.5 µM and 15 µM respectively. These compounds were shown to be 
specific inhibitors of FMDV 3Dpol and not nucleic acid chelators, as they did not affect 
activity of other viral polymerases using the same nucleic acid substrate. Molecular 
modeling docking experiments suggest that both inhibitors bind at a pocket proximal to, 
but distinct from, the NTP binding site of 3Dpol, thereby affecting indirectly RNA 
synthesis. C7F8 and C5d9 were not cytotoxic at concentrations up to at least 100 M. 
Importantly, C5D9 exhibited antiviral activity and suppressed virus production in FMDV-
infected cells with 50% and 90% effective concentrations (EC50 and EC90) of 10 M and 
20 M, respectively. The results indicate that 3Dpol inhibitors can be promising anti-
FMDV agents for use as alternative or supplementary options to contain future 
outbreaks of FMD.  
 
